Skip to main content

Advertisement

SpringerLink
Log in

Acquired neuropathies

  • Medical Progress in the Journal of Neurology
  • Published:
Journal of Neurology Aims and scope Submit manuscript

Abstract

Acquired neuropathies represent most of the neuropathies encountered in clinical practice. Hundreds of causes have been identified even though up to 41 % of patients are still classified as idiopathic (Rajabally and Shah in J Neurol 258:1431–1436, 1). Routine evaluation relies on comprehensive medical history taking, clinical examination, nerve conduction studies and laboratory tests. Other investigations such as nerve biopsy or nerve or muscle imaging are performed in specific settings. This review focuses on recent advances in acquired neuropathies.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Rajabally YA, Shah RS (2011) Dyslipidaemia in chronic acquired distal axonal polyneuropathy. J Neurol 258:1431–1436

    Article  PubMed  CAS  Google Scholar 

  2. Mauermann ML, Burns TM (2009) Pearls and Oy-sters: evaluation of peripheral neuropathies. Neurology 72:e28–e31

    Article  PubMed  Google Scholar 

  3. Dyck PJ, Overland CJ, Low PA, Litchy WJ, Davies JL, Dyck PJ, Carter RE, Melton LJ, Andersen H, Albers JW, Bolton CF, England JD, Klein CJ, Llewelyn G, Mauermann ML, Russell JW, Selvarajah D, Singer W, Smith AG, Tesfaye S, Vella A (2012) “Unequivocally abnormal” vs “usual” signs and symptoms for proficient diagnosis of diabetic polyneuropathy: cl vs n phys trial. Arch Neurol 69:1609–1614

    Article  PubMed  Google Scholar 

  4. Dyck PJ, Carter RE, Litchy WJ (2011) Modeling nerve conduction criteria for diagnosis of diabetic polyneuropathy. Muscle Nerve 44:340–345

    PubMed  Google Scholar 

  5. England JD, Gronseth GS, Franklin G, Carter GT, Kinsella LJ, Cohen JA, Asbury AK, Szigeti K, Lupski JR, Latov N, Lewis RA, Low PA, Fisher MA, Herrmann DN, Howard JF Jr, Lauria G, Miller RG, Polydefkis M, Sumner AJ (2009) Practice parameter: evaluation of distal symmetric polyneuropathy: Role of laboratory and genetic testing (an evidence-based review). Report of the American Academy of Neurology American Association of Neuromuscular and Electrodiagnostic Medicine, and American Academy of Physical Medicine and Rehabilitation. Neurology 72:185–192

    Article  PubMed  CAS  Google Scholar 

  6. Callaghan BC, Kerber K, Smith AL, Fendrick AM, Feldman E (2012) The evaluation of distal symmetric polyneuropathy: a physician survey of clinical practice. Arch Neurol 69:339–345

    Article  PubMed  Google Scholar 

  7. Koike H, Hashimoto R, Tomita M, Kawagashira Y, Iijima M, Tanaka F, Sobue G (2011) Diagnosis of sporadic transthyretin Val30Met familial amyloid polyneuropathy: a practical analysis. Amyloid 18:53–62

    Article  PubMed  CAS  Google Scholar 

  8. Faber CG, Hoeijmakers JG, Ahn HS, Cheng X, Han C, Choi JS, Estacion M, Lauria G, Vanhoutte EK, Gerrits MM, Dib-Hajj S, Drenth JP, Waxman SG, Merkies IS (2012) Gain of function Nav1.7 mutations in idiopathic small fiber neuropathy. Ann Neurol 71:26–39

    Article  PubMed  CAS  Google Scholar 

  9. Effects of Intensive Glucose Lowering in Type 2 Diabetes (2008) The action to control cardiovascular risk in diabetes study group. N Engl J Med 358:2545–2559

    Google Scholar 

  10. Tesfaye S, Chaturvedi N, Eaton SE, Ward JD, Manes C, Ionescu-Tirgoviste C, Witte DR, Fuller JH (2005) Vascular risk factors and diabetic neuropathy. N Engl J Med 352:341–350

    Article  PubMed  CAS  Google Scholar 

  11. Russell JW, Berent-Spillson A, Vincent AM, Freimann CL, Sullivan KA, Feldman EL (2008) Oxidative injury and neuropathy in diabetes and impaired glucose tolerance. Neurobiol Dis 30:420–429

    Article  PubMed  CAS  Google Scholar 

  12. Ziegler D, Rathmann W, Dickhaus T, Meisinger C, Mielck A (2008) Prevalence of polyneuropathy in pre-diabetes and diabetes is associated with abdominal obesity and macroangiopathy: the MONICA/KORA Augsburg Surveys S2 and S3. Diabetes Care 31:464–469

    Article  PubMed  CAS  Google Scholar 

  13. Visser NA, Vrancken AFJE, Van der Schouw YT, Van den Berg LH, Notermans NC (2013) Chronic idiopathic axonal polyneuropathy is associated with the metabolic syndrome. Diabetes Care 36:817–822

    Article  PubMed  Google Scholar 

  14. Dyck PJ, Clark VM, Overland CJ, Davies JL, Pach JM, Dyck PJ, Klein CJ, Rizza RA, Melton LJ III, Carter RE, Klein R, Litchy WJ (2012) Impaired glycemia and diabetic polyneuropathy: the OC IG Survey. Diabetes Care 35:584–594

    Article  PubMed  Google Scholar 

  15. Bouhassira D, Lanteri-Minet M, Attal N, Laurent B, Touboul C (2008) Prevalence of chronic pain with neuropathic characteristics in the general population. Pain 136:380–387

    Article  PubMed  Google Scholar 

  16. Vinik AI, Casellini CM (2013) Guidelines in the management of diabetic nerve pain: clinical utility of pregabalin. Diabetes Metab Syndr Obes 6:57–78

    Article  PubMed  CAS  Google Scholar 

  17. Boyle J, Eriksson MEV, Gribble L, Gouni R, Johnsen S, Coppini DV, Kerr D (2012) Randomized, placebo-controlled comparison of amitriptyline, duloxetine, and pregabalin in patients with chronic diabetic peripheral neuropathic pain impact on pain, polysomnographic sleep, daytime functioning, and quality of life. Diabetes Care 35:2451–2458

    Article  PubMed  CAS  Google Scholar 

  18. Yared JA, Tkaczuk KH (2012) Update on taxane development: new analogs and new formulations. Drug Des Devel Ther 6:371–384

    PubMed  CAS  Google Scholar 

  19. Chopra K, Tiwari V (2012) Alcoholic neuropathy: possible mechanisms and future treatment possibilities. Br J Clin Pharmacol 73:348–362

    Article  PubMed  CAS  Google Scholar 

  20. Mathey EK, Pollard JD (2013) Chronic inflammatory demyelinating polyneuropathy. J Neurol Sci (Epub ahead of print)

  21. Ayrignac X, Viala K, Koutlidis RM, Taïeb G, Stojkovic T, Musset L, Léger JM, Fournier E, Maisonobe T, Bouche P (2013) Sensory chronic inflammatory demyelinating polyneuropathy: an under-recognized entity? Muscle Nerve (Epub ahead of print)

  22. Hughes RAC, Donofrio P, Bril V, On behalf of the ICE Study Group et al (2008) Intravenous immune globulin (10% caprylatechromatography purified) for the treatment of chronic inflammatory demyelinating polyradiculoneuropathy (ICE study): a randomised placebo-controlled trial. Lancet Neurol 7:136–144

    Article  PubMed  CAS  Google Scholar 

  23. Nobile-Orazio E, Cocito D, Jann S, Uncini A, Beghi E, Messina P, Antonini G, Fazio R, Gallia F, Schenone A, Francia A, Pareyson D, Santoro L, Tamburin S, Macchia R, Cavaletti G, Giannini F, Sabatelli M, IMC Trial Group (2012) Intravenous immunoglobulin versus intravenous methylprednisolone for chronic inflammatory demyelinating polyradiculoneuropathy: a randomised controlled trial. Lancet Neurol. 11:493–502

    Article  PubMed  CAS  Google Scholar 

  24. van Schaik IN, Eftimov F, van Doorn PA, Brusse E, van den Berg LH, van der Pol WL, Faber CG, van Oostrom JC, Vogels OJ, Hadden RD, Kleine BU, van Norden AG, Verschuuren JJ, Dijkgraaf MG, Vermeulen M (2010) Pulsed high-dose dexamethasone versus standard prednisolone treatment for chronic inflammatory demyelinating polyradiculoneuropathy (PREDICT study): a double-blind, randomised, controlled trial. Lancet Neurol 9:245–253

    Article  PubMed  Google Scholar 

  25. Gorson KC, van Schaik IN, Merkies IS, Lewis RA, Barohn RJ, Koski CL, Cornblath DR, Hughes RA, Hahn AF, Baumgarten M, Goldstein J, Katz J, Graves M, Parry G, van Doorn PA (2010) Chronic inflammatory demyelinating polyneuropathy disease activity status: recommendations for clinical research standards and use in clinical practice. J Peripher Nerv Syst 15:326–333

    Article  PubMed  Google Scholar 

  26. Vanhoutte EK, Latov N, Deng C, Hanna K, Hughes RA, Bril V, Dalakas MC, Donofrio P, van Doorn PA, Hartung HP, Merkies IS (2013) Vigorimeter grip strength in CIDP: a responsive tool that rapidly measures the effect of IVIG—the ICE study. Eur J Neurol (Epub ahead of print)

  27. Gibbons CH, Freeman R (2009) Antibody titers predict clinical features of autoimmune Autonomic ganglionopathy. Auton Neurosci 146:8–12

    Article  PubMed  CAS  Google Scholar 

  28. Koike H, Hashimoto R, Tomita M et al (2012) The spectrum of clinicopathological features in pure autonomic neuropathy. J Neurol 259:2067–2075

    Article  PubMed  Google Scholar 

  29. Schroeder C, Vernino S, Birkenfeld AL et al (2005) Plasma exchange for primary autoimmune autonomic failure. N Engl J Med 353:1585–1590

    Article  PubMed  CAS  Google Scholar 

  30. Cats EA, Jacobs BC, Yuki N et al (2010) Multifocal motor neuropathy: association of anti-GM1 IgM antibodies with clinical features. Neurology 75:1961–1967

    Article  PubMed  CAS  Google Scholar 

  31. Ariga T (2011) The role of sulfoglucuronosyl glycosphingolipids in the pathogenesis of monoclonal igm paraproteinemia and peripheral neuropathy. Proc Jpn Acad Ser B Phys Biol Sci 87:386–404

    Article  PubMed  CAS  Google Scholar 

  32. Maurer MA, Rakocevic G, Leung CS, Quast I, Lukačišin M, Goebels N, Münz C, Wardemann H, Dalakas M, Lünemann JD (2012) Rituximab induces sustained reduction of pathogenic B cells in patients with peripheral nervous system autoimmunity. J Clin Invest 122:1393–1402

    Article  PubMed  CAS  Google Scholar 

  33. Dalakas MC, Rakocevic G, Salajegheh M et al (2009) Placebo-controlled trial of rituximab in igm antimyelin-associated glycoprotein antibody demyelinating Neuropathy. Ann Neurol 65:286–293

    Article  PubMed  CAS  Google Scholar 

  34. Léger JM, Viala K, Nicolas G, Créange A, Vallat JM, Pouget J, Clavelou P, Vial C, Steck A, Musset L, Marin B; For the RIMAG Study Group (France and Switzerland) (2013) Placebo-controlled trial of rituximab in IgM anti-myelin-associated glycoprotein neuropathy. Neurology (Epub ahead of print)

  35. Stork AC, van der Pol WL, van Kessel D, Lokhorst HM, Notermans NC (2012) Effect of stem cell transplantation for B-cell malignancies on disease course of associated polyneuropathy. J Neurol 259:2100–2104

    Article  PubMed  CAS  Google Scholar 

  36. Camdessanche JP, Jousserand G, Ferraud K, Vial C, Petiot P, Jerome Honnorat J, Antoine JC (2009) The pattern and diagnostic criteria of sensory neuronopathy: a case–control study. Brain 132:1723–1733

    Article  PubMed  Google Scholar 

  37. Camdessanche JP, Jousserand G, Franques J, Pouget J, Delmont E, Creange A, Kuntzer T, Maisonobe T, Abba K, Antoine JC, French CIDP study group (2012) A clinical pattern-based etiological diagnostic strategy for sensory neuronopathies: a French collaborative Study. J Peripher Nerv Syst 17:331–340

    Article  PubMed  Google Scholar 

  38. Giometto B, Grisold W, Vitaliani R, Graus F, For the PNS Euronetwork et al (2010) Paraneoplastic neurologic syndrome in the PNS Euronetwork database: a European study from 20 centers. Arch Neurol 67:330–335

    Article  PubMed  Google Scholar 

  39. Honnorat J, Cartalat-Carel S, Ricard D, Camdessanche JP, Carpentier AF, Rogemond V, Chapuis F, Aguera M, Decullier E, Duchemin AM, Graus F, Antoine JC (2009) Onco-neural antibodies and tumour type determine survival and neurological symptoms in paraneoplastic neurological syndromes with Hu or CV2/CRMP5 antibodies. J Neurol Neurosurg Psychiatry 80:412–416

    Article  PubMed  CAS  Google Scholar 

  40. Umapathi T, Tan EY, Kokubun N, Verma K, Yuki N (2012) Non-demyelinating, reversible conduction failure in Fisher syndrome and related disorders. J Neurol Neurosurg Psychiatry 83:941–948

    Article  PubMed  Google Scholar 

  41. Shahrizaila N, Goh KJ, Abdullah S, Kuppusamy R, Yuki N (2013) Two sets of nerve conduction studies may suffice in reaching a reliable electrodiagnosis in Guillain–Barré syndrome. Clin Neurophysiol (Epub ahead of print)

  42. Yuki N, Kokubun N, Kuwabara S, Sekiguchi Y, Ito M, Odaka M, Hirata K, Notturno F, Uncini A (2012) Guillain–Barré syndrome associated with normal or exaggerated tendon reflexes. J Neurol 259:1181–1190

    Article  PubMed  Google Scholar 

  43. Uncini A, Yuki N (2012) Sensory Guillain–Barré syndrome and related disorders: an attempt at systematization. Muscle Nerve 45:464–470

    Article  PubMed  Google Scholar 

  44. Kane NM, Oware A (2012) Nerve conduction and electromyography studies. J Neurol 259:1502–1508

    Article  PubMed  CAS  Google Scholar 

  45. Van den Bergh PYK, Hadden RD, Bouche P, Cornblath DR, Hahn A, Illa I, Koski CL, Leger JM, Nobile-Orazio E, Pollard J, Sommer C, Van Doorn PA, Van Schaik IN (2010) European Federation of Neurological Societies/Peripheral Nerve Society Guideline on management of chronic inflammatory demyelinating polyradiculoneuropathy: Report of a joint task force Of the European Federation of Neurological Societies and the Peripheral Nerve Society—First Revision Members of the Task Force. Eur J Neurol 17:356–363

    Article  PubMed  Google Scholar 

  46. Rajabally YA, Nicolas G, Piéret F, Bouche P, Van den Bergh PY (2009) Validity of diagnostic criteria for chronic inflammatory demyelinating polyneuropathy: a multicentre European study. J Neurol Neurosurg Psychiatry 80:1364–1368

    Article  PubMed  CAS  Google Scholar 

  47. Isoardo G, Migliaretti G, Ciaramitaro P et al (2005) Differential diagnosis of chronic dysimmune demyelinating polyneuropathies with and without anti-MAG antibodies. Muscle Nerve 31:52–58

    Article  PubMed  CAS  Google Scholar 

  48. Nasu S, Misawa S, Sekiguchi Y, Shibuya K, Kanai K, Fujimaki Y, Ohmori S, Mitsuma S, Koga S, Kuwabara S (2012) Different neurological and physiological profiles in POEMS syndrome and chronic inflammatory demyelinating polyneuropathy. J Neurol Neurosurg Psychiatry 83:476–479

    Article  PubMed  Google Scholar 

  49. Mauermann ML, Sorenson EJ, Dispenzieri A, Mandrekar J, Suarez GA, Dyck PJ, Dyck PJ (2012) Uniform demyelination and more severe axonal loss distinguish POEMS syndrome from CIDP. J Neurol Neurosurg Psychiatry 83:480–486

    Article  PubMed  Google Scholar 

  50. Park SB, Lin CS, Krishnan AV, Friedlander ML, Lewis CR, Kiernan MC (2011) Early, progressive, and sustained dysfunction of sensory axons underlies paclitaxel-induced neuropathy. Muscle Nerve 43:367–374

    Article  PubMed  Google Scholar 

  51. Osmani K, Vignes S, Aissi M, Wade F, Milani P, Lévy BI, Kubis N (2012) Taxane-induced peripheral neuropathy has good long-term prognosis: a 1- to 13-year evaluation. J Neurol 259:1936–1943

    Article  PubMed  Google Scholar 

  52. Krishnan AV, Kiernan MC (2005) Altered nerve excitability properties in established diabetic neuropathy. Brain 128:1178–1187

    Article  PubMed  Google Scholar 

  53. Arnold R, Kwai N, Lin CSY, Poynten AM, Kiernan MC, Krishnan AV (2013) Axonal dysfunction prior to neuropathy onset in type 1 diabetes. Diabetes Metab Res Rev 29:53–59

    Article  PubMed  Google Scholar 

  54. Rage M, Van Acker N, Knaapen MWM, Timmers M, Streffer J, Hermans MP, Sindic C, Meert T, Plaghki L (2011) Asymptomatic small fiber neuropathy in diabetes mellitus: investigations with intraepidermal nerve fiber density, quantitative sensory testing and laser-evoked potentials. J Neurol 258:1852–1864

    Article  PubMed  Google Scholar 

  55. Adachi Y, Sato N, Okamoto T, Sasaki M, Komaki H, Yamashita F, Kida J, Takahashi T, Matsuda H (2011) Brachial and lumbar plexuses in chronic inflammatory demyelinating polyradiculoneuropathy: MRI assessment including apparent diffusion coefficient. Neuroradiology 53:3–11

    Article  PubMed  Google Scholar 

  56. Deroide N, Bousson V, Daguet E, Dumurgier J, Wing Tin SNG, Hannouche D, Richette P, Beaudreuil J, Liote F, Levy B, Vicaut E, Laredo JD, Kubis N (2012) Muscle magnetic resonance imaging sensitivity does not Decrease in chronic, mild, or proximal lower limb neuropathies. Muscle Nerve 45:659–667

    Article  PubMed  Google Scholar 

  57. Berciano J, Gallardo E, Fernández-Torre JL, González-Quintanilla V, Infante J (2012) Magnetic resonance imaging of lower limb musculature in acute motor axonal neuropathy. J Neurol 259:1111–1116

    Article  PubMed  Google Scholar 

  58. Cartwright MS, Demar S, Griffin LP, Balakrishnan N, Harris JM, Walker FO (2013) Validity and reliability of nerve and muscle ultrasound. Muscle Nerve (Epub ahead of print)

  59. Riazi S, Bril V, Perkins BA, Abbas S, Chan VW, Ngo M, Lovblom LE, El-Beheiry H, Brull R (2012) Can ultrasound of the tibial nerve detect diabetic peripheral neuropathy? A cross-sectional study. Diabetes Care 35:2575–2579

    Article  PubMed  Google Scholar 

  60. Rajabally YA, Morlese J, Kathuria D, Khan A (2012) Median nerve ultrasonography in distinguishing neuropathy sub-types: a pilot study. Acta Neurol Scand 125:254–259

    Article  PubMed  CAS  Google Scholar 

  61. Wei M, Zhu J, Wang N, Xue Q, Liu F, Hu B, Fang J, Zhang Y (2012) Preliminary study of sural nerve morphological changes in uremic hemodialysis patients using 22-MHz high-frequency ultrasound. Muscle Nerve 46:937–942

    Article  PubMed  Google Scholar 

  62. Briani C, Campagnolo M, Lucchetta M, Cacciavillani M, Dalla Torre C, Granata G, Bergamo F, Lonardi S, Zagonel V, Cavaletti G, Ermani M, Padua L (2013) Ultrasound assessment of oxaliplatin-induced neuropathy and correlations with neurophysiologic findings. Eur J Neurol 20:188–192

    Article  PubMed  CAS  Google Scholar 

  63. Hobson-Webb LD, Massey JM, Juel VC (2013) Nerve ultrasound in diabetic polyneuropathy: correlation with clinical characteristics and electrodiagnostic testing. Muscle Nerve 47:379–384

    Article  PubMed  Google Scholar 

  64. Liu F, Zhu J, Wei M, Bao Y, Hu B (2012) Preliminary evaluation of the sural nerve using 22-MHz ultrasound: a new approach for evaluation of diabetic cutaneous neuropathy. PLoS One 7:e32730

    Article  PubMed  CAS  Google Scholar 

  65. England JD, Gronseth GS, Franklin G, Carter GT, Kinsella LJ, Cohen JA, Asbury AK, Szigeti K, Lupski JR, Latov N, Lewis RA, Low PA, Fisher MA, Herrmann D, Howard JF, Lauria G, Miller RG, Polydefkis M, Sumner AJ; American Academy of Neurology; American Association of Neuromuscular and Electrodiagnostic Medicine; American Academy of Physical Medicine and Rehabilitation. (2009) Evaluation of distal symmetric polyneuropathy: the role of autonomic testing, nerve biopsy, and skin biopsy (an evidence-based review). Muscle Nerve 39:106–115

    Google Scholar 

  66. Lauria G, Lombardi R (2012) Skin biopsy in painful and immune-mediated neuropathies. J Peripher Nerv Syst 17(Suppl 3):38–45

    Article  PubMed  CAS  Google Scholar 

  67. Doppler K, Werner C, Henneges C, Sommer C (2012) Analysis of myelinated fibers in human skin biopsies of patients with neuropathies. J Neurol 259:1879–1887

    Article  PubMed  Google Scholar 

  68. Saporta MA, Katona I, Lewis RA, Masse S, Shy ME, Li J (2009) Shortened internodal length of dermal myelinated nerve fibres in Charcot–Marie–Tooth disease type 1A. Brain 132:3263–3273

    Article  PubMed  Google Scholar 

Download references

Conflicts of interest

The authors report no conflict of interest.

Ethical standard

Our work conforms to applicable governmental regulations and discipline-appropriate professional ethical standards.

Author information

Authors and Affiliations

  1. Department of Clinical Physiology, Service de physiologie clinique-explorations fonctionnelles, AP-HP, Hôpital Lariboisière, 2 rue Ambroise Paré, 75010, Paris, France

    Pierre Lozeron & Nathalie Kubis

  2. Université Paris Diderot Sorbonne Paris Cité, Inserm U965, Paris, France

    Pierre Lozeron & Nathalie Kubis

  3. Department of Neurology, AP-HP, Hôpital Lariboisière, 2 rue Ambroise Paré, 75010, Paris, France

    Jean-Marc Trocello

Authors
  1. Pierre Lozeron
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Jean-Marc Trocello
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Nathalie Kubis
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Pierre Lozeron.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Lozeron, P., Trocello, JM. & Kubis, N. Acquired neuropathies. J Neurol 260, 2433–2440 (2013). https://doi.org/10.1007/s00415-013-6994-z

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00415-013-6994-z

Keywords

Search

Navigation